Touyun Biotech Group (HKSE:01332) Total Current Assets : HK$157.7 Mil (As of Jun. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Touyun Biotech Group's total current assets for the quarter that ended in Jun. 2024 was HK$157.7 Mil.

Touyun Biotech Group Total Current Assets Historical Data

The historical data trend for Touyun Biotech Group's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group Total Current Assets Chart

Touyun Biotech Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

364.76

468.51

268.22

322.01

162.48

Touyun Biotech Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Current Assets	Get a 7-Day Free Trial															294.11	322.01	181.52	162.48	157.65

Touyun Biotech Group Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Touyun Biotech Group's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	36.036	+	73.888	+	15.249	+	37.311
	=	162.5

Touyun Biotech Group's Total Current Assets for the quarter that ended in Jun. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	13.757	+	128.601	+	15.294	+	-2.8421709430404E-14
	=	157.7

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Touyun Biotech Group (HKSE:01332) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Touyun Biotech Group's Liquidation Value for the quarter that ended in Jun. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	13.757	-	597.417	+	0.75 * 31.85	+	0.5 * 15.294
=	-552.1

Touyun Biotech Group Total Current Assets Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Touyun Biotech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG

Website

https://www.touyunbiotech.com.hk

Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Executives

Wang Liang	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Tian Yuze	2101 Beneficial owner
Qiao Yanfeng	2201 Interest of corporation controlled by you
Qin Fen	2101 Beneficial owner

Touyun Biotech Group Headlines

No Headlines